---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-029634"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2025-12-30T23:59:59+00:00"
generated_at: "2026-05-16T12:03:28.359081+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Oncotelic closes initial $800K convertible note offering at 12% with warrants

## Summary
- Issued 32 units at $25,000 each to 21 accredited investors; total $800,000 raised.
- Each unit consists of a 2-year 12% note convertible into Oncotelic stock at $0.10/share or EdgePoint AI stock at $1.00/share.
- Each unit also includes warrants to buy 250,000 Oncotelic shares at $0.12 or 25,000 EdgePoint warrants at $1.25.
- Offering allows up to 500 units ($12.5M); prior 2023 PPM note exchanged as part of deal.
- Registration rights granted for shares issuable under the units and warrants.

## SEC filing metadata
- accession: 0001493152-25-029634
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2025-12-30T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315225029634/0001493152-25-029634-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315225029634/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-029634
- JSON: https://secwatch.observer/filing/0001493152-25-029634.json
- Plain text: https://secwatch.observer/filing/0001493152-25-029634.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.